F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,283 | -25,619 | -23,013 | -22,854 | -27,679 |
| Depreciation Amortization | 734 | 1,144 | 844 | 288 | 158 |
| Accounts payable and accrued liabilities | -1,499 | -2,847 | 2,260 | 180 | 181 |
| Other Working Capital | -7,129 | -5,917 | -8,505 | -1,226 | 1,173 |
| Other Operating Activity | 11,910 | 17,013 | 6,303 | -1,632 | 8,484 |
| Operating Cash Flow | $-27,267 | $-16,226 | $-22,111 | $-25,244 | $-17,683 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -643 | N/A | N/A | -1,972 | -323 |
| Net Acquisitions | N/A | 9,779 | 5,499 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -58,000 | -34,397 |
| Sale Of Investment | N/A | 5,000 | N/A | 34,869 | 22,314 |
| Purchase Sale Intangibles | N/A | -730 | -127 | N/A | N/A |
| Other Investing Activity | 0 | -730 | -127 | 0 | 0 |
| Investing Cash Flow | $-643 | $14,049 | $5,372 | $-25,103 | $-12,406 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,845 | 850 | 13,264 | N/A | N/A |
| Common Stock Issued | 78,346 | N/A | N/A | 41,172 | 43,538 |
| Other Financing Activity | -92 | 15,000 | 0 | 0 | 0 |
| Financing Cash Flow | $88,099 | $15,850 | $13,264 | $41,172 | $43,538 |
| Exchange Rate Effect | -166 | -48 | 180 | N/A | N/A |
| Beginning Cash Position | 18,526 | 4,901 | 8,196 | 24,133 | 10,684 |
| End Cash Position | 78,549 | 18,526 | 4,901 | 14,958 | 24,133 |
| Net Cash Flow | $60,023 | $13,625 | $-3,295 | $-9,175 | $13,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,267 | -16,226 | -22,111 | -25,244 | -17,683 |
| Capital Expenditure | -658 | N/A | N/A | -1,972 | -323 |
| Free Cash Flow | -27,925 | -16,226 | -22,111 | -27,216 | -18,006 |